Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05495087 · ClinicalTrials.gov registry record · NA
IHT for Mild Cognitive Impairment
A NA study, sponsored by University of North Texas Health Science Center.
- Recruiting
- Registry status
- NA
- Development phase
- 66
- Enrollment target
NCT05495087 is a NA study that is actively recruiting participants, run by University of North Texas Health Science Center. The registered enrollment target is 66 participants.
The verdict
NCT05495087, a NA study, is actively recruiting participants, sponsored by University of North Texas Health Science Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 66 participants
- Enrollment target
Study Summary
This phase I clinical trial will examine the safety and efficacy of intermittent hypoxia training (IHT) for up to 12 weeks to treat subjects with mild cognitive impairment (MCI).
Interventions
- DEVICE IHT Treatment
- OTHER Sham-IHT Control
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2023-02-27 |
| Est. Completion | 2026-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05495087
The ClinicalTrials.gov registry entry for NCT05495087 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Texas Health Science Center, which has 21 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which IHT Treatment is the first listed.
NCT05495087 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05495087 about?
NCT05495087 is a clinical study titled "IHT for Mild Cognitive Impairment". This phase I clinical trial will examine the safety and efficacy of intermittent hypoxia training (IHT) for up to 12 weeks to treat subjects with mild cognitive impairment (MCI).
What is the current status of trial NCT05495087?
This trial is currently recruiting. It is a NA study. The enrollment target is 66 participants. The study started on 2023-02-27. Estimated completion is 2026-04-30.
What interventions are being tested in trial NCT05495087?
The interventions under investigation include: IHT Treatment (DEVICE), Sham-IHT Control (OTHER).
Who is sponsoring clinical trial NCT05495087?
This trial is sponsored by University of North Texas Health Science Center, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.